HIV’s Hidden Weapon: Scientists Discover ‘circHIV’ & New Therapy Target

March 13, 2026 Ananya Mittal - World Editor

For decades, the human immunodeficiency virus (HIV) has presented a formidable challenge to global health. Now, a research team at Yale University has identified a previously unknown mechanism that helps the virus thrive – a circular RNA molecule, dubbed “circHIV” – potentially opening new avenues for therapeutic intervention. The discovery, published this week in the journal Nature Microbiology, sheds light on why HIV is so resilient and offers a fresh target for future treatments.

Unraveling the Role of Circular RNA in HIV Replication

Unlike typical, linear RNA, circular RNA (circRNA) forms a continuous loop without defined ends, making it remarkably stable. Researchers, led by immunologist Grace Chen, an assistant professor of immunobiology and genetics at Yale School of Medicine, began investigating whether HIV utilized this type of RNA structure. Their hunch proved correct. The team discovered that HIV encodes circRNAs, with circHIV being particularly abundant. This isn’t the first time circRNAs have been linked to viral activity; Dr. Chen’s prior research, conducted during her postdoctoral work at Stanford University, explored circular RNA immunity. Her profile at Yale School of Medicine details her extensive work in this field.

The study involved sequencing RNA from HIV-infected cells, detecting the looped structures not only within infected cells but also in the blood plasma of individuals living with HIV. Crucially, experiments demonstrated a direct correlation between circHIV levels and HIV gene activity: reducing circHIV lowered viral activity, while increasing it boosted replication. Further investigation revealed that circHIV binds to the HIV Tat protein – a key regulator of viral transcription – effectively amplifying the virus’s ability to turn on its genes.

What are Circular RNAs and Why Do They Matter?

RNA, or ribonucleic acid, is a crucial molecule involved in carrying genetic information from DNA to proteins. While most RNA is linear, circRNAs are formed when a loop is created, resulting in a closed structure. This loop protects the RNA from degradation, making it far more stable than its linear counterparts. Scientists are increasingly recognizing the importance of circRNAs in various biological processes, including gene regulation and immune responses. The discovery of circHIV highlights the virus’s ability to exploit this natural cellular mechanism to its advantage.

Implications for HIV Treatment and Research

The identification of circHIV as a facilitator of viral replication represents a significant step forward in understanding HIV pathogenesis. While current antiretroviral therapies (ART) effectively suppress the virus, they do not eliminate it from the body. Individuals living with HIV must continue ART to manage the infection and prevent transmission. The emergence of circHIV as a potential therapeutic target offers the possibility of developing new strategies to disrupt the viral lifecycle and potentially achieve a functional cure.

The Yale team’s findings suggest that therapies aimed at reducing circHIV levels could complement existing ART regimens. However, it’s important to note that this research is still in its early stages. Further studies are needed to fully elucidate the role of circHIV in HIV infection and to assess the feasibility and safety of targeting it therapeutically. The research team is currently exploring potential strategies to disrupt circHIV production or function.

Study Details and Limitations

The study, led by Grace Chen and co-first authors Prisca Obi and Lichong Yan, involved both in vitro experiments (conducted in the lab) and analysis of samples from individuals living with HIV. The researchers utilized RT-qPCR and northern blot techniques to detect circHIV, and RNA immunoprecipitation and in vitro pulldown assays to investigate its interactions with the Tat protein. The full study is available in Nature Microbiology.

A key limitation of the study is that it primarily focused on the molecular mechanisms underlying circHIV’s function. Further research is needed to determine how these findings translate to the broader context of HIV infection and disease progression. The study involved a relatively minor sample size of 18 people living with HIV, and further validation in larger cohorts is necessary.

The Path Forward: From Discovery to Potential Therapies

The discovery of circHIV is likely to spur further research into the role of circRNAs in other viral infections. Understanding how viruses manipulate these cellular mechanisms could lead to the development of novel antiviral strategies. For HIV specifically, the next steps involve:

  • Developing targeted therapies: Researchers will explore ways to specifically inhibit circHIV production or function without disrupting essential cellular processes.
  • Investigating clinical relevance: Larger studies are needed to determine whether circHIV levels correlate with disease progression or treatment response.
  • Exploring combination therapies: The potential of combining circHIV-targeted therapies with existing ART regimens will be investigated.

This research builds on decades of work to understand and combat HIV. As Grace Chen noted in a Yale News report, the discovery represents a significant step towards unlocking the secrets of this formidable virus. While a cure for HIV remains a long-term goal, this new understanding of circHIV offers a renewed sense of hope for future treatments and improved outcomes for individuals living with the virus.